2014
DOI: 10.4172/jaa.10000101
|View full text |Cite
|
Sign up to set email alerts
|

Preclinical and Clinical Profile of HIV-1 Integrase Strand-transfer Inhibitor GS-9224 Compared to its Parent Compound GS-9160

Abstract: Materials and Methods Compounds GS-9224 and GS-9160 were synthesized at Gilead Sciences, Inc. L-870,810 was synthesized by Combi Blocks, Inc. (San Diego, CA). RAL was synthesized by Naeja Pharmaceuticals, Inc. (Edmonton, Alberta Canada). All three compounds have a purity of >95% as determined by analytical reversed phase HPLC using a Phenomenex Luna C18 column and UV detection at 214 nm and 254 nm. The structures of these three INSTIs are shown in (Figure 1). Cells MT-2 cells were obtained from Stanford Univer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 45 publications
(73 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?